Navigation Links
Physical therapists offer low-cost solution to high-cost expenditures for acute low back pain
Date:8/12/2008

ALEXANDRIA, VA, August 12, 2008 The American Physical Therapy Association (APTA) concurs with findings from a recent study published in Spine (Volume 33, Number 16) demonstrating that active physical therapy for patients with acute low back pain is associated with better clinical outcomes, decreased use of prescription medications, MRI and epidural injections, and lower healthcare costs than passive physical therapy.

For pain of a 'mechanical' origin such as low back pain, hands-on therapy to mobilize the spine and exercises designed to alleviate low back pain have been shown to be particularly effective and have long-lasting effects on patients. According to the study's lead researcher and APTA member Julie Fritz, PT, PhD, ATC, Clinical Outcomes Research Scientist at Salt Lake City's Intermountain Healthcare and associate professor at the University of Utah, "Physical therapists are often one of the first health care providers that patients with acute low back pain encounter - whether they are referred by medical doctors or visit them directly - which offers evidenced-based PTs a tremendous opportunity to help patients recover."

Physical therapist management is a low-cost, high-value alternative to medication and surgery to deal with certain musculoskeletal pain. According to Fritz, "Considering that low back pain will affect between sixty and eighty percent of Americans during their lifetime, the potential cost savings of an early, effective intervention to prevent individuals from progressing to chronic disability may be considerable."

The study consisted of a retrospective review of 471 patients, ages 18-60. One hundred thirty-two patients (28 percent) received active physical therapy (involving a high percentage of active exercise) and 339 (72 percent) received non-adherent care (defined as involving greater than 25% passive treatments such as hot/cold treatment, ultrasound, and electrical stimulation).

Patients
'/>"/>

Contact: Stephanie Block
stephanieblock@apta.org
703-706-3397
American Physical Therapy Association
Source:Eurekalert

Page: 1 2

Related medicine news :

1. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
2. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
3. Cognitive Activities Protect Against Alzheimers -- Social and Physical Activities Not Enough
4. Physical Therapist Provides Injury Analysis for Fantasy Football
5. Empowerment Program Gets Patients on the PATH to Managing the Physical and Emotional Effects of Psoriatic Arthritis
6. This October, the American Physical Therapy Associations National Physical Therapy Month to Focus on Nations Obesity Epidemic
7. New study likely to fuel debate over annual physical exams
8. Blue Cross of California and the California Governors Council on Physical Fitness and Sports Launch Live Like a Champion Tour
9. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
10. The impact of physical activity on weight-bearing knee joint
11. The Physical Therapy Profession Remains in High Demand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Trust Inc. (NYSE: CRE ) ("Care" or the ... dividend of $0.17 per share of common stock. The dividend ... on December 14, 2009. ,, About Care ... estate investment and finance company investing in healthcare-related real estate and ...
(Date:12/4/2009)... Medithrive, Inc. has won the Patient,s Choice Award ... by popular vote conducted by the online website, ... SF Bay community has selected Medithrive as the preeminent ... rapid rise and popularity of Medithrive confirms the obvious: ...
(Date:12/4/2009)... Dec. 4 The American Association of Homes and Services ... the Community Living and Supportive Services (CLASS) provisions remain ... are essential for providing support to elders, people with disabilities ... pass a health care reform bill that will make it ...
(Date:12/4/2009)... The large, two-day free health clinic sponsored by the ... Wednesday and Thursday is not just for the sick but ... a doctor recently. All participants in the health clinic will ... the three previous large free clinic events this fall in ...
(Date:12/4/2009)... Dec. 4 Pamela Bowen, Chief Information Officer at ... "Chief Innovation Officer" Appy Award for transforming Crescent,s business ... are nominated based on their innovative usage of Salesforce ... of customer success to their sales, marketing, partner, service, ...
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... sleep patterns in a type of anesthesia that are ... The anesthetic used in the study, known as ethyl ... more thoroughly investigate ways of treating sleep disorders and ... the studys co-authors and an associate professor of psychology, ...
... Md., April 16, 2008 The U.S. Pharmacopeial ... Program participants. USP is the official standards-setting body ... States. It also sets standards that are widely ... dietary supplements. USPs internship program offers the opportunity ...
... A California Superior Court,today issued a temporary restraining ... Stern and SEIU to cease and desist the,stalking ... officers,directors, and staff of the California Nurses Association/National ... Stern are prohibited from stalking,threatening, or following CNA/NNOC ...
... April 16 Do you know anyone,who,s a ... take personality tests, the cranberry would turn out ... in these little red gems. But the antioxidants,deserve ... ), Often identified in food by their ...
... weekend faced 13.4% lower chance of recovery, study finds , , ... a cardiac arrest are 13.4 percent worse if you are ... according to new research. , Even after taking into account ... age, gender and other illnesses, the lower survival rate remains ...
... around our middle could be making us hungrier, so we ... fat. Dr. Yaiping Yang and his colleagues at the ... Ontario found abdominal fat tissue can reproduce a hormone that ... will change in the way we think about and treat ...
Other Medicine News:Health News:USP announces 2008 summer internship program participants 2Health News:Court Orders Service Union and Its President Andy Stern: Stop Stalking and Harassing Registered Nurse Leaders and Staff of California Nurses Assn/NNOC 2Health News:Court Orders Service Union and Its President Andy Stern: Stop Stalking and Harassing Registered Nurse Leaders and Staff of California Nurses Assn/NNOC 3Health News:Cranberries: The Little Fruit With a Great Big Punch 2Health News:Cranberries: The Little Fruit With a Great Big Punch 3Health News:Your belly fat could be making you hungrier 2
(Date:12/4/2009)... The U.S. Food and Drug Administration (FDA) ... option for the treatment of schizophrenia and manic or ... aged 13-17 years old. ,, The updated Zyprexa ... increased potential for weight gain and hyperlipidemia in adolescents ...
(Date:12/4/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... webcast. Principal investigators will discuss the data presentations ... featured at the 51st American Society of Hematology (ASH) ... a.m. CT/10:00 a.m. ET on Monday, December 7, 2009. ...
(Date:12/4/2009)... Chemistry World recently highlighted a new report ... America ( PhRMA ) that identifies 97 new drugs ... The report found that the 97 products in ... either in human clinical trials or awaiting approval by the ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study 5085 1InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study 5085 2Clipa for a Cure 3A New Pink Instant Handbag Hanger Benefits Breast Cancer Research 58508 1Clipa for a Cure 3A New Pink Instant Handbag Hanger Benefits Breast Cancer Research 58508 2BASF Podcast 3A The Chemical Reporter Why Does Fluoride Make Your Teeth Hard 3F 58504 1BASF Podcast 3A The Chemical Reporter Why Does Fluoride Make Your Teeth Hard 3F 58504 2BASF Podcast 3A The Chemical Reporter Why Does Fluoride Make Your Teeth Hard 3F 58504 3
... Survival vs. Interferon-Alpha, COLLEGEVILLE, Pa., Nov. 26 ... WYE ), announced today that the,European Commission has ... with advanced renal cell carcinoma (RCC),who have at ... is the only,approved cancer therapy that specifically inhibits ...
... VioQuest,Pharmaceuticals (OTC Bulletin Board: VQPH) today ... of Lenocta(TM) (sodium stibogluconate), a novel,protein tyrosine ... immune stimulant approved for the treatment of ... cancers. The open-label Phase IIa study is,designed ...
Other Medicine Technology:Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 2Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 3Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 4Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 5Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 6VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 2VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 3VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 4
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Dual offset femoral stems, hip stems that provide unique and competitive features....
Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de...
Medicine Products: